Historical Stock Price
ETFs Holding ACRX »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/10/2022 $0.52 $0.56 $0.51 $0.54 1.34M
01/11/2022 $0.55 $0.57 $0.54 $0.57 562.60K
01/12/2022 $0.57 $0.58 $0.53 $0.54 885.80K
01/13/2022 $0.56 $0.56 $0.49 $0.52 992.90K
01/14/2022 $0.52 $0.52 $0.49 $0.52 544.30K
AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. DSUVIA® (known as DZUVEO™ in Europe) and Zalviso® are both focused on the treatment of acute pain, and each utilize sufentanil, delivered via a non-invasive route of sublingual administration, for use in medically supervised settings. Co.'s portfolio includes ARX-02 Higher Strength Sufentanil Sublingual Tablet for cancer breakthrough pain in opioid-tolerant patients; and ARX-03 Combination Sufentanil/Triazolam Sublingual Tablet for mild sedation and pain relief during painful procedures in a physician's office.
ACRX historical stock prices picture
AcelRx Pharmaceuticals (ACRX) has the following price history information. Looking back at ACRX historical stock prices for the last five trading days, on January 10, 2022, ACRX opened at $0.52, traded as high as $0.56 and as low as $0.51, and closed at $0.54. Trading volume was a total of 1.34M shares. On January 11, 2022, ACRX opened at $0.55, traded as high as $0.57 and as low as $0.54, and closed at $0.57. Trading volume was a total of 562.60K shares. On January 12, 2022, ACRX opened at $0.57, traded as high as $0.58 and as low as $0.53, and closed at $0.54. Trading volume was a total of 885.80K shares. On January 13, 2022, ACRX opened at $0.56, traded as high as $0.56 and as low as $0.49, and closed at $0.52. Trading volume was a total of 992.90K shares. On January 14, 2022, ACRX opened at $0.52, traded as high as $0.52 and as low as $0.49, and closed at $0.52. Trading volume was a total of 544.30K shares.

ACRX Historical Stock Prices By Date:

ACRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AcelRx Pharmaceuticals shares, starting with a $10,000 purchase of ACRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/19/2012
End date: 01/14/2022
Start price/share: $2.89
End price/share: $0.52
Dividends collected/share: $0.00
Total return: -82.01%
Average Annual Total Return: -15.77%
Starting investment: $10,000.00
Ending investment: $1,799.19
Years: 9.99
Date Close
01/10/2022$0.54
01/11/2022$0.57
01/12/2022$0.54
01/13/2022$0.52
01/14/2022$0.52
ACRX is categorized under the Healthcare sector; below are some other companies in the same sector:

ACST Historical Stock Prices
ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices
ADRO Historical Stock Prices

Also explore: ACRX shares outstanding history

Email EnvelopeFree ACRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ACRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.